Finch Therapeutics & Takeda Expand Collaboration to Develop Microbiome Therapeutics Using Finchs HumanFirst Discovery Platform

Finch & Takeda to target Crohns disease under expanded collaborationFinch Therapeutics Group Inc. Finch and Takeda Pharmaceutical Company Limited Takeda; TSE4502NYSETAK announced today the expansion of their collaboration to develop microbiomebased...